10-K Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001144204-12-018624`
Period End Date	20111231
Filing Date	20120330
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	bpth-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 49 Cash Flow Statement 66 Stockholders Equity 55

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$238.56K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Cash	`Cash`	$567.25K	USD	Point-in-time
Grants receivable	`ReceivablesNetCurrent`	$244.48K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$153.00K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$88.40K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.44K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$72.99K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	58.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.15M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.40M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$644.44K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	58.33M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.40M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.87M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$3.04M	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	928,667.00	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$791.46K	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$579.75K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.08M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.46M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.11M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.23M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$88.40K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$121.54K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$67.97K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$46.08K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$67.84K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$16.30K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$41.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$39.54K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$74.22K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$316.13K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.76K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$246.76K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$316.13K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,325,169 and 49,400,605 shares issued and outstanding as of 12/31/11 and 12/31/10, respectively	`CommonStockValue`	$49.40K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,325,169 and 49,400,605 shares issued and outstanding as of 12/31/11 and 12/31/10, respectively	`CommonStockValue`	$58.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$9.72M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$12.41M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$278.60K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$7.19M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$9.55M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.11M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.59M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.76M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.74M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$-76.48K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.37M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.86M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.61M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.06M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.54M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.23M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.11M	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	19 Qtrs
Revenue	`Revenues`	-	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$1.22M	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$1.13M	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$6.07M	USD	19 Qtrs
Total operating expense	`OperatingExpenses`	$9.87M	USD	19 Qtrs
Total operating expense	`OperatingExpenses`	$2.33M	USD	Annual
Total operating expense	`OperatingExpenses`	$2.37M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-9.87M	USD	19 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.37M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-2.33M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$2.91K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$76.31K	USD	19 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.30K	USD	Annual
Other income	`OtherNonoperatingIncome`	$244.48K	USD	19 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	Annual
Other expense	`OtherNonoperatingExpense`	$3.09K	USD	19 Qtrs
Other expense	`OtherNonoperatingExpense`	$852.00	USD	Annual
Other expense	`OtherNonoperatingExpense`	$636.00	USD	Annual
Total Other Income	`NonoperatingIncomeExpense`	$244.93K	USD	Annual
Total Other Income	`NonoperatingIncomeExpense`	$2.27K	USD	Annual
Total Other Income	`NonoperatingIncomeExpense`	$317.70K	USD	19 Qtrs
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.08M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.36M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-9.55M	USD	19 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	19 Qtrs
Net Loss	`NetIncomeLoss`	$-2.08M	USD	Annual
Net Loss	`NetIncomeLoss`	$-496.26K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-56.21K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-407.20K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-239.05K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-596.69K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-226.21K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-432.80K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-143.20K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-533.05K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-81.99K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-9.55M	USD	19 Qtrs
Net Loss	`NetIncomeLoss`	$-2.36M	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	19 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	48.15M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	43.20M	shares	19 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	53.84M	shares	Annual

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.08M	USD	Annual
Net loss	`NetIncomeLoss`	$-496.26K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-56.21K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-407.20K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-239.05K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-596.69K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-226.21K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-432.80K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-143.20K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-533.05K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.99K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.55M	USD	19 Qtrs
Net loss	`NetIncomeLoss`	$-2.36M	USD	Annual
Amortization	`AdjustmentForAmortization`	$211.71K	USD	Annual
Amortization	`AdjustmentForAmortization`	$197.27K	USD	Annual
Amortization	`AdjustmentForAmortization`	$791.46K	USD	19 Qtrs
Technology impairment	`AssetImpairmentCharges`	$345.00K	USD	19 Qtrs
Technology impairment	`AssetImpairmentCharges`	$345.00K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$300.00K	USD	19 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$382.92K	USD	Annual
Stock options and warrants	`ShareBasedCompensation`	$2.95M	USD	19 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$477.36K	USD	Annual
Grants receivable	`IncreaseDecreaseInReceivables`	$244.48K	USD	Annual
Grants receivable	`IncreaseDecreaseInReceivables`	$-244.48K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$153.00K	USD	19 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$64.60K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-520.04K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$48.44K	USD	19 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-24.55K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.30K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-18.14K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$316.13K	USD	19 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$69.37K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.05M	USD	19 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.15M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.15M	USD	Annual
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$859.71K	USD	19 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$170.06K	USD	Annual
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$229.66K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-229.66K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-859.71K	USD	19 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.06K	USD	Annual
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	19 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	19 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.05M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.44M	USD	19 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.03M	USD	Annual
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.05M	USD	Annual
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.86M	USD	19 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.03M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-328.68K	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$713.69K	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$952.25K	USD	19 Qtrs
Cash, beginning of period	`Cash`	$238.56K	USD	Point-in-time
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$567.25K	USD	Point-in-time
Cash, end of period	`Cash`	$238.56K	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$567.25K	USD	Point-in-time
Interest	`InterestPaid`	$445.00	USD	19 Qtrs
Interest	`InterestPaid`	$44.00	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	19 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	19 Qtrs

Stockholders Equity 55 line items

Line Item	Tag	Value	Unit	Period
Stock option award	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$42.22K	USD	1 Quarter
Common stock and warrants for cash	`IssuanceOfCommonStockAndWarrantsValue`	$225.00K	USD	Annual
Common stock and warrants for cash	`IssuanceOfCommonStockAndWarrantsValue`	$165.00K	USD	1 Quarter
Common stock sold shares to be issued	`StockIssuableValue`	$278.60K	USD	Annual
Common stock sold shares to be issued	`StockIssuableValue`	$675.00K	USD	1 Quarter
Common stock sold for investor warrant exercise	`StockIssuedDuringPeriodValueStockWarrantsExercised`	$576.00K	USD	Annual
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalOther`	$382.92K	USD	Annual
Warrants issued for services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$36.05K	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$477.36K	USD	Annual
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$148.73K	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$30.77K	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$150.16K	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$142.29K	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.39M	USD	1 Quarter
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$147.69K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$363.92K	USD	Annual
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$75.07K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$4.07K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$34.84K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$4.89K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$552.23K	USD	Annual
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$251.90K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$19.02K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$441.89K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$12.89K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$60.51K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$6.24K	USD	1 Quarter
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$26.77K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.08M	USD	Annual
Net loss	`NetIncomeLoss`	$-496.26K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-56.21K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-407.20K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-239.05K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-596.69K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-226.21K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-432.80K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-143.20K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-533.05K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.99K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.55M	USD	19 Qtrs
Net loss	`NetIncomeLoss`	$-2.36M	USD	Annual
Ending balance	`StockholdersEquity`	$3.11M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.59M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.76M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.74M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-76.48K	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.37M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$5.00M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.86M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.42M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.91M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.61M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.06M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.54M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.